• 13 Hits
  • Search Condition : Filter (MeSH = Skull / drug effects)
Species Resource Title
Human and Animal Cells MC3T3-E1(RCB1126) Calcium hydroxide suppresses Porphyromonas endodontalis lipopolysaccharide-induced bone destruction.
Human and Animal Cells ST2(RCB0224) Superior bone-inducing potential of rhBMP9 compared to rhBMP2.
Zebrafish Tg(UAS:EGFP) Osteocrin, a peptide secreted from the heart and other tissues, contributes to cranial osteogenesis and chondrogenesis in zebrafish.
Human and Animal Cells MC3T3-E1(RCB1126) Osteoblastic bone formation is induced by using nanogel-crosslinking hydrogel as novel scaffold for bone growth factor.
Human and Animal Cells RAW 264(RCB0535) Effect of addition of hyaluronic acids on the osteoconductivity and biodegradability of synthetic octacalcium phosphate.
Human and Animal Cells MC3T3-E1(RCB1126) , ST2(RCB0224) Clodronate stimulates osteoblast differentiation in ST2 and MC3T3-E1 cells and rat organ cultures.
Human and Animal Cells ST2(RCB0224) The expression of matrix metalloproteinase-13 and osteocalcin in mouse osteoblasts is related to osteoblastic differentiation and is modulated by 1,25-dihydroxyvitamin D3 and thyroid hormones.
Human and Animal Cells 10T1/2(RCB0247) Enhancement of osteogenesis in vitro and in vivo by a novel osteoblast differentiation promoting compound, TAK-778.
Human and Animal Cells RAW 264(RCB0535) Enhanced bone regeneration via multimodal actions of synthetic peptide SVVYGLR on osteoprogenitors and osteoclasts.
Mice RBRC01828 New BRAF knockin mice provide a pathogenetic mechanism of developmental defects and a therapeutic approach in cardio-facio-cutaneous syndrome.
Human and Animal Cells MC3T3-E1(RCB1126) Excess iron inhibits osteoblast metabolism.
Human and Animal Cells MC3T3-E1(RCB1126) Reduction of protein phosphatase 2A Cα enhances bone formation and osteoblast differentiation through the expression of bone-specific transcription factor Osterix.
Human and Animal Cells ST2(RCB0224) Stimulation of ectopic bone formation in response to BMP-2 by Rho kinase inhibitor: a pilot study.